Cargando…
Intranasal delivery in glioblastoma treatment: prospective molecular treatment modalities
Glioblastoma multiforme (GBM) is rare and fatal glioma with limited treatment options. Treatments provide minimal improvement in prognosis and only 6.8% of GBM patients have a life expectancy greater than five years. Surgical resection of this malignant glioma is difficult due to its highly invasive...
Autores principales: | Morales, Daniel E., Mousa, Shaker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136349/ https://www.ncbi.nlm.nih.gov/pubmed/35647354 http://dx.doi.org/10.1016/j.heliyon.2022.e09517 |
Ejemplares similares
-
Glioblastoma Treatment Modalities besides Surgery
por: Zhang, Hao, et al.
Publicado: (2019) -
Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation
por: Rhea, Elizabeth M., et al.
Publicado: (2020) -
Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System
por: Semyachkina-Glushkovskaya, Oxana, et al.
Publicado: (2022) -
Harnessing Intranasal Delivery Systems of Sumatriptan for the Treatment of Migraine
por: Assadpour, Sara, et al.
Publicado: (2022) -
Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects
por: Bharali, Dhruba J., et al.
Publicado: (2011)